EYLEA 8mg for the treatment of neovascular age-related macular degeneration and diabetic macular edema
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
Lumvoa gains US FDA approval for thyroid eye disease with class-first broad label
2
DEX implant shows benefit across RVO subgroups in real-world retrospective study
3
European Dry Eye Society Congress 2026: real-world evidence on Artelac Complete in dry eye disease
4